Unique resonance technology in Spain to study cellular metabolism, hosted by IBEC
Search Results for:
Nanomedicine seeks solutions against rare diseases
Despite its importance in the fight against pandemics such as COVID-19, a lesser-known face of nanomedicine is its potential to contribute to solutions to so-called rare or minority diseases. Coinciding with February 28th, the world day for rare diseases, experts invited by the Nanomed Spain platform and the Sant Joan de Déu Research Institute (IRSJD) present the latest advances in nanomedicine against three of these disorders: muscular dystrophy, cystic fibrosis and Fabry disease.
Zaida Álvarez wins the Rafael Hervada prize
At the press conference held this morning at the San Rafael Hospital, the Rafael Hervada prize was announced. Zaida Álvarez, current researcher at IBEC, has been awarded for her pioneering research on regeneration of spinal cord injuries using nanotechnology at the Northwestern University, Chicago, USA.
The lack of cellular prion protein might lead to epilepsy symptoms and learning deficits
Researchers at IBEC, in collaboration with hospitals and international partners, have observed that the deficiency of the cellular prion protein leads to behavioral deficits, learning impairment, and enhanced epilepsy-like excitability of the brain, in mice.
Online IBEC Seminar: Stefano Pulchino
Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS Stefano Pulchino, University of Cambridge There are currently no approved therapies to slow … Read more
Online IBEC Seminar: Stefano Pulchino
Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS Stefano Pulchino, University of Cambridge There are currently no approved therapies to slow … Read more
Online IBEC Seminar: Stefano Pulchino
Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS Stefano Pulchino, University of Cambridge There are currently no approved therapies to slow … Read more
Complementary biotechnology plan presented at IBEC
The strategic research programme in the area of biotechnology applied to healthcare that was presented at the Institute for Bioengineering of Catalonia (IBEC), appears in the media by investing 32 million more in biotechnology.
PhD Discussions: Giulia Fornabaio and Shubham Tanwar
Biomechanics of the progression of colorectal carcinomas Giulia Fornabaio, Synthetic morphogenesis group According to the World Health Organization, cancer is one of the main causes of death worldwide, with colorectal … Read more
PhD Discussions: Giulia Fornabaio and Shubham Tanwar
Biomechanics of the progression of colorectal carcinomas Giulia Fornabaio, Synthetic morphogenesis group According to the World Health Organization, cancer is one of the main causes of death worldwide, with colorectal … Read more